A Non-randomized Phase II Study of Apatinib and Tegafur Gimeracil Oteracil Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Latest Information Update: 27 Jul 2022
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Rivoceranib (Primary)
- Indications Carcinoma; Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 24 Aug 2021 Status changed from recruiting to completed.
- 29 Feb 2020 Results (n=31) presented at the 2020 Multidisciplinary Head and Neck Cancers Symposium
- 16 Mar 2018 Status changed from not yet recruiting to recruiting.